The review presents the main physiological functions of thrombin. The procoagulant and anticoagulant activities of the key serine protease are discussed in both physiological and pathological conditions of hemostasis. The involvement of thrombin in atherogenesis, as well as its role as a mediator of vascular dysfunction and inflammation in both the peripheral and central nervous system, is highlighted. A pronounced imbalance between the pro- and anticoagulant systems leads to an increase in thrombin formation and creates conditions for the development of thrombosis. Tests that allow direct or indirect assessment of thrombin’s functional activity are presented. The potential applications of direct thrombin inhibitors and direct blockers of thrombin PAR receptors in vascular neurology are also considered.
18 December 2021 in Journal of Medical Case Reports
Background: Patients with celiac disease present with not only gastrointestinal symptoms but also extraintestinal manifestations such as anemia, osteopathy, dermatitis herpetiformis, and celiac neuropathy. Despite a fairly wide range of celiac neuropathies, we report a case of the acrodystrophic variant of celiac polyneuropathy, which has not been previously described. Case presentation: A 41-year-old Ukrainian male suffered from symmetric, sensorimotor axonal polyneuropathy and encephalopathy associated with celiac disease, which is characterized by severe trophic disorders in the lower extremities (trophic ulcers, hyperkeratosis, and anhidrosis). Acrodystrophic changes in the lower extremities were due to both neurogenic and direct immunoinflammatory damaging effects. Clinical–electrophysiological dissociation was also noted, which was represented by a gross axonal lesion with the preservation of muscle strength. The absence of enteropathic manifestations was accompanied by the pronounced histological changes in the duodenal mucosa by IIIb stage of Marsh. A gluten-free diet in combination with membrane plasma exchange and intravenous pulse methylprednisolone was prescribed to reduce the severity of sensory disorders and regression of encephalopathy within 7 months. Conclusion: Celiac disease may be a potential cause of neuropathy and encephalopathy in adult patients. Further immunosuppressive treatment protocols for both intestinal and extraintestinal manifestations of celiac disease are required.
21 March 2025 in S.S. Korsakov Journal of Neurology and Psychiatry
Objective. To study the prognostic value of von Willebrand factor (vWF) in peracute and acute periods of cardioembolic stroke (CES) in patients receiving unfractionated (UFH) and low molecular weight heparin (LMWH). Material and methods. Thirty patients with CES receiving UFH/LMWH and acetylsalicylic acid were examined. The comparison group included 15 patients with non-cardioembolic stroke without heparin therapy. On Days 2—3 and 7—10 from the disease onset, patients were evaluated using the NIHSS and HAS-BLED scales; also, brain CT, Doppler ultrasound, echocardiography, complete blood count and blood chemistry, vWF measurement, and induced platelet aggregation test with ristocetin, arachidonic acid, and collagen were performed. Results. During LMWH therapy in the peracute period, increased platelet aggregation with ristocetin (p=0.038) and vWF levels (p=0.017) were found versus the comparison group. A correlation between vWF level and platelet aggregation with collagen was identified (p=0.010, r=0.461). No inhibition of platelet function with ristocetin was observed during the entire period of therapy with both LMWH and UFH. During LMWH treatment, increased platelet activity with ristocetin was observed in the acute period, compared with patients receiving UFH (p=0.007). There were no significant differences in the change in the vWF levels in patients with and without hematuria. There was a correlation between the HAS-BLED score and hematuria in the semiquantitative analysis of erythrocytes in urine (p=0.041, r=0.375), as well as a correlation between the vWF levels and the ASPECT score (p=0.001, r=–0.576). Conclusion. The concomitant use of heparin with antiplatelet agents, particularly with aspirin in CES, enhances its anticoagulant activity and inhibits platelets in the test with arachidonic acid. Continued high ristocetin- and collagen-induced platelet aggregation supports the use of vasoprotective agents activating metabolic processes in the walls of blood vessels to correct persistent endothelial dysfunction.
Nemaline myopathies are a heterogeneous group of congenital structural myopathies characterized by rod-shaped inclusions in the sarcoplasm and/or nuclei of muscle fibers. Pathogenic variants in the ACTA1 gene represent the second most frequent cause of nemaline myopathies, with 90 % exhibiting autosomal dominant inheritance. Homozygous pathogenic variants typically are manifested by severe infantile phenotype 2B, whereas the phenotypic spectrum of mild and moderate forms has yet to be systematically categorized. This article presents an 8-year-old patient with homozygous actinopathy (NM_001100.4(ACTA1):c.661GC (p.Val221Leu)) corresponding to the typical phenotype of congenital myopathy-2A. Distinctive features of this case were the presence of distal hand joint hypermobility, rimmed vacuolar changes on histological analysis, and abnormal white matter signal intensity on neuroimaging. Magnetic resonance pattern of fatty infiltration and edematous changes in the pelvic girdle and lower extremity muscles were also presented. Combined inheritance of pathogenic homozygous variants in the COQ8A gene (formerly ADCK3) (NM_020247.5(COQ8A):c.1189GA (p.Val397Met)) required differential diagnosis with primary coenzyme Q10 deficiency, which may involve skeletal muscle pathology.